RVTY
NYSE
Life Sciences Tools & Services
$110.52
USD
+$4.08 (+3.83%)
At close: Jul 21, 2026, 4:00 PM EDT
Market Cap:
$12.27B
Volume:
1.6M
Previous Close
$106.44
Day Range
$102.36 - $112.30
52 Week Range
$81.22 - $118.30
Average Volume (10 Days)
1.1M
P/E Ratio (TTM)
51.21
Dividend Yield
0.26%
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
CEO
Dr. Prahlad Singh
Headquaters
Waltham, MASSACHUSETTS, US
Founded
1965
Employees
11,000